![]() |
![]() |
| Chronobiol Med > Volume 7(4); 2025 > Article |
|
Ethics Statement
The study protocol was reviewed and approved by the Institutional Ethics Committee, Amity University, Lucknow (Approval No.: AUL/IEC/2025/037; Date: 10 October 2025).
Conflicts of Interest
Availability of Data and Material
Data generated in this study will be available upon reasonable request, following institutional ethics approval.
Author Contributions
Conceptualization: Devesh Ojha. Data curation: Devesh Ojha. Formal analysis: Devesh Ojha. Investigation: Devesh Ojha, Laxmi Ojha. Methodology: Devesh Ojha, Laxmi Ojha. Project administration: Devesh Ojha. Resources: Laxmi Ojha. Software: Devesh Ojha. Supervision: Laxmi Ojha. Validation: Devesh Ojha, Laxmi Ojha. Visualization: Devesh Ojha. Writing—original draft: Devesh Ojha. Writing—review & editing: Laxmi Ojha.
| Health domain | Common issues in night shift workers | Key mechanisms involved | Supporting references |
|---|---|---|---|
| Cardiovascular | Hypertension, coronary artery disease, stroke | Loss of nocturnal BP dipping, increased sympathetic activity | [11,19,20,24] |
| Metabolic | Obesity, insulin resistance, type 2 diabetes | Nighttime eating, altered glucose metabolism | [12,13,21-23] |
| Mental health | Depression, anxiety, burnout | Sleep deprivation, altered neurotransmitter rhythms | [6,14,24] |
| Cancer | Breast, prostate cancer | Melatonin suppression, impaired DNA repair | [1,9,10,18,26,27] |
| Immune function | Increased inflammation | Disrupted cytokine release patterns | [6,14,29] |
|
Timepoint (month)* |
||||||
|---|---|---|---|---|---|---|
| Baseline (0) | 6 | 12 | 18 | 24 | Continuous | |
| Eligibility & consent | ✓ | |||||
| Registry entry | ✓ | |||||
| Demographics & medical history | ✓ | |||||
| Wearable monitoring (sleep, activity, light) | ✓ | ✓ | ✓ | ✓ | ✓ | Continuous |
| Work schedule logging | ✓ | ✓ | ✓ | ✓ | ✓ | Continuous |
| Metabolic panel (HbA1c, glucose, lipids) | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Cardiovascular markers (BP, arterial stiffness) | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Mental health (PHQ-9, GAD-7, PSQI) | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Inflammatory markers (hs-CRP, IL-6) | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Circadian phase testing (transcriptomic, metabolomic±DLMO) | ✓ | ✓ | ✓ | |||
* baseline: eligibility, consent, demographics, registry entry; follow-up: assessments at baseline, 6, 12, 18, and 24 months; continuous data: wearables and digital work schedules; quarterly: metabolic, cardiovascular, mental health, and inflammatory assessments; annual: comprehensive circadian phase testing (transcriptomic, metabolomic, optional DLMO).
SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials; BP, blood pressure; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; PSQI, Pittsburgh Sleep Quality Index; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; DLMO, dim-light melatonin onset.

![]() |
![]() |